Skip to content

Critical Illness / Sun Life Syariah

Salam Healthier Future Assurance (SHIFA) Essential

Syariah Critical Illness agency Full brief · 2026-05-16

SHIFA Essential is not a critical-illness lump-sum policy.

★ The Insurer’s Play

analytical interpretation

Why this product exists

To sell lump-sum protection against a small set of high-cost diagnoses — specifically, to capture whole-household budgets rather than single lives and sell a private "speed layer" sitting above public BPJS cover.

What the insurer wants the agent to do

Steer the agent to bundle several family members onto one policy, position it as a fast private top-up to BPJS, not a replacement, and explain the specific co-payment mechanism clearly.

Inferred from: family-package structureBPJS positioningPOJK 36/2025 co-paymentSyariah / pilgrimage structuresavings / return-of-premium benefitcompetitive positioning (§4)

Our read of the insurer’s design intent — not their stated words. Use it to judge fit, not as a fact about the policy.

Who this fits — and who it doesn’t

✓ Fits when…

  • Age 30–50, Muslim, household income Rp 15M–60M/month
  • Explicitly syariah-conscious — has BSI or Maybank Syariah account, or prioritises halal financial products, or requests a syariah alternative when offered conventional insurance
  • Does NOT have comprehensive hospitalisation insurance (no employer card, BPJS Kesehatan only, or basic BPJS Class 1 only), specifically worried about what happens when a major disease like cancer or heart failure hits
  • Has family history of one or more of the four covered conditions (stroke, cancer, cardiovascular, kidney failure) — the diagnosis risk is viscerally real for them
  • Employed professional or business owner aged 35–50 who travels regionally for work — the Asia plan tiers (Asia 1 / Asia 2) offer geographic coverage that BPJS and many employer plans do not
  • Values the holistic recovery model — SHIFA Essential explicitly covers nutritional counselling, psychological support, and physiotherapy post-treatment, which most basic health plans do not
  • Moderate to high risk-aversion; wants certainty that hospitalisation costs will be covered, not an investment upside story

~ Borderline — qualify carefully

  • Already has a comprehensive employer health plan (including hospitalisation) — SHIFA Essential becomes a top-up / coordination-of-benefits tool, which can still work but the case is more complex; the CI Allowance feature (50% extra on top of employer plan payout) is the pitch anchor
  • Non-Muslim customer who wants the syariah structure for ethical/investment-separation reasons — valid, but do not assume syariah preference; ask explicitly
  • Age 55–60 — still within entry age range (insured up to age 60); works but the annual contribution will be higher at older ages and the remaining years to age 100 shrink the renewable horizon somewhat
  • Customer who already has a lump-sum CI product elsewhere — SHIFA Essential complements it (covers actual costs vs the lump-sum's income-replacement function) but the combined premium burden needs to be tested against their budget

✕ Not a fit when…

  • Customer who is primarily seeking a lump-sum cash payout upon CI diagnosis — SHIFA Essential is not that product; redirect to AlliSya CI Hasanah, Allianz Critical+, or any conventional CI lump-sum product
  • Prospects with pre-existing conditions in any of the four categories — the 180-day waiting period and pre-existing exclusion mean early claims in those conditions will be denied; mis-selling risk is very high
  • Customers seeking an investment or savings component — SHIFA Essential has no investment element; Tabarru' funds are pooled risk funds, not savings; the Celebration Benefit (Rp 25M–35M) is not a meaningful savings return
  • Budget-constrained prospects for whom even the minimum annual contribution (Rp 1,478,000) is a stretch — annual renewability plus possible contribution increases at each anniversary means the affordability question is not just about year one
  • Customers who want comprehensive health insurance (fever, maternity, dental, general outpatient) — SHIFA Essential covers ONLY the four CI conditions; it is not a general health plan

The trade-offs — when it wins, when it doesn’t

No product wins for everyone. Here’s when Salam Healthier Future Assurance (SHIFA) Essential is the right call — and when a different product is.

SYARIAH-CONSCIOUS, WORRIED ABOUT COST OF SERIOUS ILLNESS

Lead:SHIFA Essential

Only syariah product in Sun Life ecosystem that covers actual medical costs for 4 major killer diseases; renewable to 100; Asian coverage option available.

SYARIAH-CONSCIOUS, WANTS A LUMP SUM ON CI DIAGNOSIS

Lead:AlliSya CI Hasanah (Allianz Life Syariah)

SHIFA Essential pays bills, not cash. If the customer wants income replacement or cash freedom on diagnosis, AlliSya CI Hasanah is the right structure.

SYARIAH-CONSCIOUS, ALREADY HAS EMPLOYER HEALTH PLAN

50% extra on approved bills even after employer plan pays. Annual Rp 500M–2B limit provides genuine additional firepower.

BPJS KESEHATAN ONLY, WORRIED ABOUT QUALITY OF CARE FOR SERIOUS ILLNESS

Lead:SHIFA Essential Indo 1

BPJS covers costs but cannot guarantee hospital quality or private room access; SHIFA Essential fills the gap for the four highest-mortality conditions.

WANTS CI PROTECTION, NO SYARIAH PREFERENCE

Lead:Allianz SmartHealth Maxi Violet (conventional) or Allianz Flexi Medical

Conventional health products from Allianz; wider condition coverage; no Tabarru' complexity.

MOBILE PROFESSIONAL, WORKS ACROSS SOUTHEAST ASIA

Lead:SHIFA Essential Asia 1 or Asia 2

Coverage extends to all of Asia except HK/JP/SG; rare in syariah health space; useful for Indonesians working in Malaysia, Thailand, or Gulf countries.

JUST WANTS THE CHEAPEST OPTION, NO CI-SPECIFIC PREFERENCE

BPJS handles general hospitalisation; SHIFA Essential is a CI-specialist overlay, not a BPJS replacement.

LOOKING FOR INCOME REPLACEMENT WHILE RECOVERING FROM CI

Lead:CI lump-sum product (AlliSya CI Hasanah or conventional CI alternative)

SHIFA Essential covers hospital bills; it does not replace lost income. A lump-sum CI product does that.

HAS BSI TAKAFUL HEALTH PRODUCT

CURRENTLY UNDERGOING TREATMENT FOR ONE OF THE 4 CONDITIONS

Key facts

Coverage

  • Sum assured: not yet extracted from RIPLAY
  • Policy term: not yet extracted
  • Payment term: not yet extracted
  • Covered conditions: stroke, cancer, cardiovascular disease, kidney failure (4 major critical illnesses)

Premium

Not yet extracted from RIPLAY/brochure.

Target Customer

Individuals seeking syariah-compliant critical illness protection against the 4 most common life-threatening diagnoses.

Key Features

  • Covers 4 major critical illnesses (stroke, cancer, heart/cardiovascular, kidney failure)
  • Syariah-compliant (takaful basis)
  • Agency distribution channel
  • Also available via CIMB Niaga Syariah bancassurance channel
  • SHIFA brand positioning: “Salam Healthier Future Assurance”

⚠ Compliance red flags & mis-selling warnings

1. Reimbursement vs lump-sum — critical disclosure The single most important disclosure at point of sale. SHIFA Essential pays actual medical bills up to the annual limit. It does NOT pay a lump sum on diagnosis. Any agent who describes this product as “dapat uang tunai kalau kena penyakit kritis” (you receive cash when you’re diagnosed with CI) is mis-selling. The distinction must be explained clearly, and the customer must confirm understanding before application is submitted.

2. 180-day waiting period — non-negotiable Symptoms, investigations, or a diagnosis of any of the four covered conditions that occur within the first 180 days of the policy being in force (or 180 days from the most recent policy reinstatement) result in a total claim denial for that condition. The policy will not cover that condition ever again. Agents must disclose this before sale, not after a claim is denied. If a customer has any current or recent history of the four conditions, the agent must advise underwriting review before taking an application.

3. Annual renewable means contribution is not fixed Contributions are reviewed at each policy anniversary. Sun Life can change the contribution rate with 30 business days’ notice. In an environment of rising medical inflation in Indonesia, historical contribution levels are not a guide to future costs. Agents must not imply or state that the current annual figure will remain constant. The phrase “kontribusi bisa berubah setiap tahun” must be in the agent’s disclosure.

4. Geographic coverage fine print — Asia excludes HK, Japan, Singapore The three excluded markets are Hong Kong, Japan, and Singapore — the three most commonly visited Asian destinations for Indonesian business travellers and frequent flyers. Customers who specifically need coverage in those markets need to be redirected to a different product or supplemented with travel/expat health insurance. Agents must not describe the Asia plans as “coverage across Asia” without specifying the three exclusions.

5. Tabarru’ fund deficit risk The Tabarru’ pool can run a deficit if claims exceed contributions. In a deficit scenario, Sun Life provides a Qardh (interest-free loan) to cover shortfalls. This Qardh must be repaid from future surpluses before surplus sharing resumes. Customers should be aware that the strength of the syariah fund is partly dependent on Sun Life’s financial health and willingness to provide Qardh. This must be disclosed as a risk, not buried.

6. Ujrah 55% must be disclosed The Wakalah fee structure allocates 55% of every contribution to Sun Life as a management fee, with only 45% entering the Tabarru’ risk pool. This is a material fact. Agents must disclose the Ujrah percentage when discussing contribution structure. Failure to disclose is a compliance violation under POJK regulations governing syariah insurance products.

7. One SHIFA Essential policy per insured — limit Each insured person can hold only one SHIFA Essential policy. If a customer already has an existing SHIFA Essential policy (however sold — agency or bancassurance), a second application must be rejected. Agents must verify this at application stage.

8. POJK 36/2025 co-payment (Risiko Sendiri) disclosure Under the regulatory environment in force, customers must be informed of any co-payment or self-retention provisions. The room-upgrade prorata formula in SHIFA Essential (if a customer upgrades their room above plan entitlement, all benefits are proportionally reduced) functions as a de facto co-payment. Agents must explain this clearly: taking a room above the plan’s maximum daily room rate will trigger proportional reductions across all benefits, not just the room benefit.


Internal training guidance. Always confirm against the current RIPLAY/policy — the policy is the binding document.

Expert · technical detail

Raw fields

Entity type
syariah
Channel
agency
Category
critical-illness
Benchmark carrier
no
Extraction quality
pdf-downloaded
First cataloged
2026-05-03
Last updated
2026-05-20
Brief date
2026-05-16
Analyst confidence
Medium — RIPLAY v.CIMB_v.1 is the CIMB Niaga Syariah bancassurance version; a separate agency-facing RIPLAY (v0.8-agency) is noted in the master-log filename but the document examined carries the CIMB label. Core benefit tables, akad structure, and exclusion lists are confirmed from PDF. Contribution tables by age-band are not disclosed in available documents (only a sample case for male age 40 at Rp 2,024,000/year for Plan Indo 1 is provided). Final agency-channel terms should be cross-checked against the agency-specific RIPLAY version.

Source documents

On-disk (read-only upstream):
documents/sun-life-syariah/syariah/shifa-essential/riplay-2026-05-20.pdf
documents/sun-life-syariah/syariah/shifa-essential/brochure-2026-05-20.pdf

Insurer product page ↗

How Critical Illness products differ

Still building · 77% coverage

No product wins every dimension — these are trade-offs, not a scoreboard. Where the dataset can’t yet support hard medians, we show the observed range and the analyst’s read.

  • Most agency CI products are renewable-term structures (5/10/15-year periods) rather than whole-life CI cover.
  • Early CI + Major CI + Premium Waiver triple-stack (Allianz pattern) is differentiating relative to single-stage products.
  • Booster/return-of-premium tail benefits are increasingly standard for premium-tier CI.
  • Sharia CI products follow conventional structure with Tabarru' / Wakalah bil Ujrah overlay.
  • TMLI tm-ci-guard and tm-critical-guard are publishing-gap B set; lower confidence on full-feature comparison.

Coverage caveat: Critical-illness category is structurally heterogeneous: comprehensive CI lump-sum, early-stage CI add-ons, gender/condition-specific products, and recurring-payment CI. Aggregate quantitative benchmarking across these structures is misleading; sub-category qualitative comparison is preferred. Briefs rely on qualitative comparison plus direct PDF reading. (sample: ~23 products)

Expert · full Strategic Brief

1. The 60-Second Pitch

SHIFA Essential is not a critical-illness lump-sum policy. Most people hear “critical illness insurance” and picture a cheque arriving after a cancer diagnosis. SHIFA Essential works differently: when the insured is diagnosed with one of the four big killers — stroke, cancer, cardiovascular disease, or kidney failure — the product pays actual hospital and treatment bills up to an annual limit, renewable every year until age 100.

Think of it as a dedicated health insurance plan that activates only when one of those four conditions is confirmed. You do not get a lump sum to use as you like. You get your medical costs covered — inpatient care, outpatient visits, dialysis, surgery, palliative care, and even recovery services like physiotherapy, nutritional counselling, and psychological counselling — up to a plan-specific annual ceiling.

Four plans are available. Two cover treatment inside Indonesia only. Two extend coverage across Asia (excluding Hong Kong, Japan, and Singapore). Annual benefit limits run from Rp 500 million to Rp 2 billion per condition depending on the plan chosen. The product runs on a syariah Tabarru’ + Wakalah bil Ujrah structure, is regulated by OJK, and is renewable annually with premium reviews possible at each anniversary.

In one line: Syariah-compliant hospital-and-treatment coverage for the four leading killer diseases, with genuine Asian geographic reach, renewable to age 100 and structured so that actual medical costs — not just a cash payout — are what gets replaced.

The structural distinction matters at the point of sale: agents must not position SHIFA Essential as a CI lump-sum product. It is a CI-triggered health reimbursement product. That is both its key differentiator and its most important compliance disclosure.


2. Headline Numbers Decoded

The RIPLAY provides one sample illustration: male, age 40, Plan Indo 1, policy issued 22 November 2025. Annual contribution Rp 2,024,000. Below is a full decode of the benefit table and the sample case, followed by a representative hospitalisation scenario.

Agent note on the sample contribution: Rp 2,024,000/year for male age 40 under Plan Indo 1 (Rp 500M annual limit, Indonesia only) works out to under Rp 170,000/month. That is a relatively accessible price point for the coverage quantum, though the actual contribution at older ages will be materially higher (age tables not disclosed in available documents). Agents must not quote the Rp 2,024,000 figure to prospects outside that age-gender-plan combination.


SAMPLE CASE

Insured

Male, age 40, Plan Indo 1

Annual

Rp 2,024,000

Batas

Rp 500,000,000 per condition

per policy year

Death CI

Rp 200,000,000

Geography

Indonesia only

PLAN COMPARISON TABLE

Indo 1 Indo 2

---------- ----------

Geography Indonesia Indonesia

Annual limit Rp 500M Rp 1.0B

per condition

Room/night Rp 1.0M Rp 1.0M

(max, twin) (twin bed) (twin bed)

Death CI Rp 200M Rp 200M

Celebration Rp 25M Rp 25M

Benefit

Nutritionist Rp 300K/ Rp 300K/

(per visit) visit visit

Psych consult Rp 400K/ Rp 400K/

(per visit) visit visit

Physio/OT/ST Rp 300K/ Rp 300K/

(per visit) visit visit

Medical aids Rp 25M per Rp 25M per

(per cond.) condition condition

Home care Rp 500K/ Rp 500K/

(per day) day day

Wig (cancer) Rp 4M Rp 4M

Stroke home Rp 30M Rp 30M

equipment

Asia 1 Asia 2

---------- ----------

Geography Asia Asia

(ex HK/ (ex HK/

JP/SG) JP/SG)

Annual limit Rp 1.0B Rp 2.0B

per condition

Room/night Rp 1.5M Rp 1.5M

(max, single) (single) (single)

Death CI Rp 300M Rp 400M

Celebration Rp 30M Rp 35M

Benefit

Nutritionist Rp 450K/ Rp 650K/

visit visit visit

Psych consult Rp 650K/ Rp 800K/

visit visit visit

Physio/OT/ST Rp 450K/ Rp 650K/

visit visit visit

Medical aids Rp 35M per Rp 45M per

condition condition condition

Home care Rp 700K/ Rp 800K/

per day day day

Wig (cancer) Rp 5M Rp 5M

Stroke home Rp 50M Rp 50M

equipment

BENEFITS COMMON TO ALL PLANS

ICU

Actual cost (no separate cap)

Doctor visits

Actual cost; max 2 visits/day

during hospitalisation

Surgery

Actual cost

Cancer outpatient

Actual cost; cancer monitoring

max 5 yrs post-treatment

Day surgery

Actual cost

Dialysis

Max Rp 200M/year (all plans)

Kidney transplant

Max Rp 750M per transplant;

max 2 transplants during

policy life; does NOT reduce

annual CI limit

Palliative

Actual cost (inpatient +

outpatient)

Max hosp days

150 days per policy year

Max recovery

60 days home care per

condition; 60 nutritionist

visits; 30 psych visits; 90

physio/OT/speech visits

ADDITIONAL BENEFITS

Death (CI cause)

Rp 200M–400M depending on plan

Celebration Bft

Rp 25M–35M; paid once if no

claim filed for 12 months after

last approved claim; paid once

per policy lifetime

CI Allowance

50% of approved hospital bill

minus coordination of benefits

already paid by other insurer;

reduces annual CI limit

REPRESENTATIVE SCENARIO

Male, 40, Plan Indo 1, kidney failure

Hospital bill

Rp 300,000,000

Approved by SHIFA

Rp 300,000,000

(within Rp 500M annual limit)

Remaining limit

Rp 200,000,000

(this policy year)

Next year reset

Rp 500,000,000

If same patient also has employer

health plan that paid Rp 100M

SHIFA pays top-up of Rp 200M

(coordination of benefits applies)

PLUS CI Allowance = 50% of

approved bill (Rp 300M) minus

employer plan payout (Rp 100M) =

Rp 50M CI Allowance

Total SHIFA payout:Rp 250M

Annual limit consumed:Rp 250M

UJRAH / CONTRIBUTION SPLIT

Tabarru' (risk fund)

45% of contribution

Ujrah (fee to SLFI)

55% of contribution

Policy print fee

Rp 150,000 if hardcopy

elected

Note

55% Ujrah allocation is high.

For a Rp 2,024,000 annual contribution,

Rp 1,113,200 goes to Sun Life as fees;

only Rp 910,800 enters the risk pool.

Agents must disclose this clearly.

3. Ideal Customer Profile

Sweet Spot — Lead with SHIFA Essential

  • Age 30–50, Muslim, household income Rp 15M–60M/month
  • Explicitly syariah-conscious — has BSI or Maybank Syariah account, or prioritises halal financial products, or requests a syariah alternative when offered conventional insurance
  • Does NOT have comprehensive hospitalisation insurance (no employer card, BPJS Kesehatan only, or basic BPJS Class 1 only), specifically worried about what happens when a major disease like cancer or heart failure hits
  • Has family history of one or more of the four covered conditions (stroke, cancer, cardiovascular, kidney failure) — the diagnosis risk is viscerally real for them
  • Employed professional or business owner aged 35–50 who travels regionally for work — the Asia plan tiers (Asia 1 / Asia 2) offer geographic coverage that BPJS and many employer plans do not
  • Values the holistic recovery model — SHIFA Essential explicitly covers nutritional counselling, psychological support, and physiotherapy post-treatment, which most basic health plans do not
  • Moderate to high risk-aversion; wants certainty that hospitalisation costs will be covered, not an investment upside story

Borderline Fit — Qualify Carefully

  • Already has a comprehensive employer health plan (including hospitalisation) — SHIFA Essential becomes a top-up / coordination-of-benefits tool, which can still work but the case is more complex; the CI Allowance feature (50% extra on top of employer plan payout) is the pitch anchor
  • Non-Muslim customer who wants the syariah structure for ethical/investment-separation reasons — valid, but do not assume syariah preference; ask explicitly
  • Age 55–60 — still within entry age range (insured up to age 60); works but the annual contribution will be higher at older ages and the remaining years to age 100 shrink the renewable horizon somewhat
  • Customer who already has a lump-sum CI product elsewhere — SHIFA Essential complements it (covers actual costs vs the lump-sum’s income-replacement function) but the combined premium burden needs to be tested against their budget

Do Not Pitch

  • Customer who is primarily seeking a lump-sum cash payout upon CI diagnosis — SHIFA Essential is not that product; redirect to AlliSya CI Hasanah, Allianz Critical+, or any conventional CI lump-sum product
  • Prospects with pre-existing conditions in any of the four categories — the 180-day waiting period and pre-existing exclusion mean early claims in those conditions will be denied; mis-selling risk is very high
  • Customers seeking an investment or savings component — SHIFA Essential has no investment element; Tabarru’ funds are pooled risk funds, not savings; the Celebration Benefit (Rp 25M–35M) is not a meaningful savings return
  • Budget-constrained prospects for whom even the minimum annual contribution (Rp 1,478,000) is a stretch — annual renewability plus possible contribution increases at each anniversary means the affordability question is not just about year one
  • Customers who want comprehensive health insurance (fever, maternity, dental, general outpatient) — SHIFA Essential covers ONLY the four CI conditions; it is not a general health plan

4. Decision Framework


SYARIAH-CONSCIOUS, WORRIED ABOUT COST OF SERIOUS ILLNESS

Lead:SHIFA Essential

Only syariah product in Sun Life ecosystem that covers actual medical costs for 4 major killer diseases; renewable to 100; Asian coverage option available.

SYARIAH-CONSCIOUS, WANTS A LUMP SUM ON CI DIAGNOSIS

Lead:AlliSya CI Hasanah (Allianz Life Syariah)

SHIFA Essential pays bills, not cash. If the customer wants income replacement or cash freedom on diagnosis, AlliSya CI Hasanah is the right structure.

SYARIAH-CONSCIOUS, ALREADY HAS EMPLOYER HEALTH PLAN

50% extra on approved bills even after employer plan pays. Annual Rp 500M–2B limit provides genuine additional firepower.

BPJS KESEHATAN ONLY, WORRIED ABOUT QUALITY OF CARE FOR SERIOUS ILLNESS

Lead:SHIFA Essential Indo 1

BPJS covers costs but cannot guarantee hospital quality or private room access; SHIFA Essential fills the gap for the four highest-mortality conditions.

WANTS CI PROTECTION, NO SYARIAH PREFERENCE

Lead:Allianz SmartHealth Maxi Violet (conventional) or Allianz Flexi Medical

Conventional health products from Allianz; wider condition coverage; no Tabarru' complexity.

MOBILE PROFESSIONAL, WORKS ACROSS SOUTHEAST ASIA

Lead:SHIFA Essential Asia 1 or Asia 2

Coverage extends to all of Asia except HK/JP/SG; rare in syariah health space; useful for Indonesians working in Malaysia, Thailand, or Gulf countries.

JUST WANTS THE CHEAPEST OPTION, NO CI-SPECIFIC PREFERENCE

BPJS handles general hospitalisation; SHIFA Essential is a CI-specialist overlay, not a BPJS replacement.

LOOKING FOR INCOME REPLACEMENT WHILE RECOVERING FROM CI

Lead:CI lump-sum product (AlliSya CI Hasanah or conventional CI alternative)

SHIFA Essential covers hospital bills; it does not replace lost income. A lump-sum CI product does that.

HAS BSI TAKAFUL HEALTH PRODUCT

CURRENTLY UNDERGOING TREATMENT FOR ONE OF THE 4 CONDITIONS

5. Product Benchmarking


STRUCTURAL DIMENSIONS

PRODUCT TYPE

SHIFA Essential:CI-triggered health reimbursement; NOT lump-sum CI

AlliSya CI Hasanah:Lump-sum CI (early + major CI structure)

Allianz SmartHealth:Comprehensive hospitalisation (all conditions)

Allianz Flexi Medical:Comprehensive hospitalisation (all conditions)

Read:SHIFA Essential occupies a distinct niche — it is the only syariah product in the landscape reviewed that pays actual bills for CI conditions rather than cash. This is a genuine structural differentiator, but also a source of confusion at point of sale.

CONDITIONS COVERED

SHIFA Essential:4 (stroke, cancer, cardiovascular, kidney failure)

AlliSya CI Hasanah Plan Lite:3

AlliSya CI Hasanah Plan Max:77

Allianz SmartHealth:All conditions (not condition-specific)

Read:SHIFA Essential's 4-condition scope is narrow by lump-sum CI standards but deep by health- coverage standards — it covers actual care costs for those 4, not just a trigger payment.

GEOGRAPHIC COVERAGE

SHIFA Essential Asia 1/2:All Asia except Hong Kong, Japan, Singapore

AlliSya CI Hasanah:Indonesia only (standard; agent confirmation req'd)

Allianz SmartHealth:Indonesia; some plans extend internationally

Read:SHIFA Essential's Asia option is rare in the syariah health space and is a genuine differentiator for mobile professionals.

COVERAGE TERM

SHIFA Essential:Annual renewable to age 100

AlliSya CI Hasanah:20 or 30 years (fixed term, then re-underwrites)

Allianz SmartHealth:Annual renewable

Read:SHIFA Essential and SmartHealth share the annual-renewable structure; CI Hasanah offers a longer fixed-term certainty window (no re-underwriting within the term).

ENTRY AGE

SHIFA Essential insured:20–60 yrs

SHIFA Essential policyholder:18–80

AlliSya CI Hasanah:To age 55 (Plan Max, 10yr PPT) or 60 (Plan Lite)

Read:Similar entry age range. Upper bound at 60 for insured is a limitation; older applicants cannot start new SHIFA Essential coverage.

MINIMUM CONTRIBUTION / PREMIUM

SHIFA Essential:Rp 1,478,000/year

AlliSya CI Hasanah:Age/SA-dependent; not disclosed in available docs

Allianz SmartHealth:Age/plan- dependent; not disclosed

Read:At Rp 2,024,000/year for male age 40, Plan Indo 1, SHIFA Essential is accessible for the mass-affluent segment. Older ages and higher plans will be materially more expensive.

ECONOMIC DIMENSIONS

BENEFIT STRUCTURE

SHIFA Essential:Reimburses actual medical costs up to annual limit (Rp 500M to Rp 2B per condition)

AlliSya CI Hasanah:Lump-sum on diagnosis (Rp 100M to Rp 5B SA range; major CI = 100% of SA)

Allianz SmartHealth:Reimburses actual costs across all conditions

Read:For a cancer patient with Rp 400M in annual treatment costs, SHIFA Essential Indo 2 (Rp 1B limit) covers costs for 2.5 years. A CI lump-sum of Rp 1B pays out once and the customer manages cash. Different use cases; not substitutes.

ANNUAL LIMIT RESET

SHIFA Essential:Annual limit resets each policy anniversary

AlliSya CI Hasanah:SA reduces by each major CI claim (no reset)

Read:SHIFA Essential's annual reset is economically superior for chronic or recurring CI treatment. Cancer patients who need multi-year therapy benefit from the reset structure.

UJRAH / FEE TRANSPARENCY

SHIFA Essential:55% Ujrah / 45% Tabarru' split disclosed in RIPLAY

AlliSya CI Hasanah:Not disclosed at equivalent detail level

Read:The 55% Ujrah ratio is high and must be disclosed to customers. It means only 45 cents of every Rp 1 in contribution enters the mutual risk pool. This is a common structure in short-term syariah products but it must not be obscured.

DOUBLE CLAIM / COORDINATION

SHIFA Essential:CI Allowance — 50% of approved bill on top of any other insurer's payment; this means the product CAN pay even when another insurer has already covered the bill

AlliSya CI Hasanah:N/A (lump-sum)

Allianz SmartHealth:Coordination of benefits (no double dip)

Read:The CI Allowance is a genuine feature for customers who have employer health plans. They get a bonus 50% payment on top of what the employer plan pays, subject to annual limit. This is a strong selling point vs standard coordination-of-benefits products.

KIDNEY TRANSPLANT COVERAGE

SHIFA Essential:Rp 750M per transplant; max 2 transplants; does NOT reduce annual CI limit

AlliSya CI Hasanah:N/A (lump-sum)

Read:The kidney transplant benefit is unusually generous and worth calling out specifically — it sits outside the annual Rp 500M–2B limit, meaning a patient can claim both the annual CI limit AND a transplant benefit in the same year.

CELEBRATION BENEFIT (WELLNESS BONUS)

SHIFA Essential:Rp 25M–35M if no claim filed for 12 months post-last-approved claim; paid once per policy lifetime

AlliSya CI Hasanah:Hasanah Cash — 100% premium refund at term end if no major CI claim

Read:Celebration Benefit is modest (once in a lifetime, up to Rp 35M) vs the Hasanah Cash structure which returns all premiums. However, SHIFA Essential is a health product, not a savings product, so the benchmark is different.

SHARIA-SPECIFIC DIMENSIONS

AKAD STRUCTURE

SHIFA Essential:

Akad Tabarru':Mutual risk-sharing pool. Contributions from all policyholders go into Dana Tabarru'; claims are paid from this pool. Policyholders are participants (peserta) helping each other — not buying risk transfer from Sun Life.

Akad Wakalah bil Ujrah:Sun Life acts as wakil (agent/manager) on behalf of policyholders to manage the Tabarru' fund. The Ujrah (55% of contribution) is the fee for this management service. Distinction from conventional: In conventional insurance, premium goes to the insurer who owns it and bears the risk. In syariah,

contribution is split:the Tabarru' portion belongs collectively to the participants; the Ujrah portion is Sun Life's service fee. Claims are paid from the Tabarru' pool, not from Sun Life's own capital (except in cases where Tabarru' fund is in deficit and Sun Life provides Qardh — interest-free loan — to cover claims).

SURPLUS UNDERWRITING

Mechanism:If total contributions to the Tabarru' fund exceed total claims + reinsurance costs + technical reserves in a policy year, the surplus is shared:

Policyholder:50%

Sun Life:40%

Tabarru' fund:10% Conditions to qualify: - Policy active and in-force for ≥12 months at year-end - No claim filed during the calculation period - All contributions paid in full - Policy still active at payment date Minimum threshold: Surplus < Rp 50,000 is donated to a government-authorised social institution rather than paid to the policyholder.

Read:Surplus sharing is a genuine syariah benefit — conventional policyholders receive no share of insurer profits. However, the claim condition means only clean- record policyholders benefit; anyone who has claimed gets nothing from the surplus pool.

TABARRU' FUND DEFICIT RISK

If the Tabarru' fund runs a deficit

(claims exceed contributions +

reserves), Sun Life provides a

Qardh (interest-free loan) to cover

the shortfall. This Qardh must be

repaid from future surplus before

new surplus sharing occurs.

Customer disclosure requirement:Agents must disclose that the Tabarru' fund can run into deficit and that in such a scenario, the fund's health depends on Sun Life's willingness and capacity to provide Qardh. This is structurally different from conventional where the insurer's balance sheet is the backstop.

WAKALAH FEE TRANSPARENCY (COMPLIANCE)

SHIFA Essential Ujrah:55% of every contribution goes to Sun Life as a management fee. This is high relative to investment-linked syariah products (where Ujrah is typically lower) but is typical for short-term syariah health products due to the annual operating cost structure.

POJK compliance:The Ujrah split must be disclosed in the RIPLAY and to the customer at point of sale. It is disclosed in SHIFA Essential's RIPLAY — agents must relay this clearly, not bury it.

COMPARISON WITH CONVENTIONAL HEALTH

Structurally equivalent:Same hospital bill reimbursement outcome. The patient who claims gets the same amount whether the policy is syariah or conventional. Structural difference: - Risk is borne collectively by the Tabarru' pool in syariah; by the insurer in conventional - Surplus goes back to participants in syariah; stays with insurer in conventional - Riba (interest) is avoided in syariah fund management; not a consideration in conventional For Muslim customers who care

about these distinctions:the syariah structure matters. For those who don't, the benefit outcome is the same and should be sold on feature merit, not halal branding.

POSITIONING SUMMARY

SHIFA Essential sits in an unusual

position

it is the only syariah

health product in the landscape

reviewed that is explicitly designed

for CI-specific conditions rather

than general hospitalisation. It does

not compete head-on with AlliSya CI

Hasanah (lump-sum) or Allianz Flexi

Medical / SmartHealth (comprehensive

health). It occupies the intersection

CI-focused + health-reimbursement +

syariah + Asian geographic reach.

Legacy Income agents should understand

this product primarily as competitive

intelligence on what Sun Life Syariah

is offering to the same Muslim

mass-affluent segment that Allianz

Life Syariah targets. The positioning

implication

when a prospect says

"I want something syariah for serious

illness," agents now face a genuine

alternative from Sun Life that is

structurally different (reimbursement

vs lump-sum) but occupies similar

shelf space in the customer's mind.

6. Field Talking Points (EN + ID)

Customer-facing script — use the EN / ID toggle (top-right) to switch language.

Opening — The Syariah Health Angle

“Have you ever thought about what would happen to your family’s finances if you were diagnosed with cancer, or had a stroke? Most people I talk to have BPJS, maybe a company health card — but those cover day-to-day illness. The bills that come with a serious diagnosis are in a completely different league. SHIFA Essential from Sun Life Syariah is specifically designed for that gap, and it’s fully syariah-compliant — Tabarru’ pooling, Wakalah structure, OJK-approved.”

“Pernah kepikiran nggak, kalau kamu atau pasangan kamu kena kanker atau stroke, keuangan keluarga bakal gimana? Kebanyakan orang punya BPJS, mungkin juga kartu kesehatan dari kantor — tapi itu untuk sakit biasa. Kalau kena penyakit berat, biayanya beda level. SHIFA Essential dari Sun Life Syariah itu dirancang khusus untuk situasi seperti itu, dan strukturnya syariah — pakai akad Tabarru’ dan Wakalah, sudah disetujui OJK.”

Structural Value Prop — Reimbursement vs Lump-Sum

“Here’s the key thing to understand about SHIFA Essential — it works differently from most CI products. Instead of giving you a lump sum when you’re diagnosed, it pays your actual hospital and treatment bills, up to a generous annual limit. So if your cancer treatment costs Rp 300 million this year, you claim Rp 300 million. Next year, your limit resets. It’s not a cash payout; it’s a dedicated health cover for serious disease.”

“Ini yang penting untuk dipahami dulu: SHIFA Essential itu beda dari produk asuransi penyakit kritis pada umumnya. Bukan langsung kasih uang tunai waktu didiagnosis — tapi bayarin tagihan rumah sakit dan biaya perawatan kamu yang sebenarnya, sampai batas tahunan yang cukup besar. Jadi kalau biaya pengobatan kanker kamu tahun ini Rp 300 juta, ya diklaim Rp 300 juta. Tahun depan, batasnya reset lagi. Ini bukan uang tunai bebas; ini proteksi kesehatan khusus untuk penyakit berat.”

The Geographic Coverage Pitch

“One thing that stands out about the Asia plan options — if you travel or work across Southeast Asia regularly, SHIFA Essential covers your treatment in most of Asia, not just Indonesia. So if you’re in Kuala Lumpur or Bangkok and something serious happens, you’re not paying out of pocket and waiting to be reimbursed months later. The plan covers Asia, excluding Hong Kong, Japan, and Singapore, but that still covers most of the region where Indonesians actually work and travel.”

“Yang menarik dari pilihan Plan Asia — kalau kamu sering kerja atau pergi ke luar negeri di Asia, SHIFA Essential juga cover perawatan di sebagian besar Asia, bukan cuma Indonesia. Jadi kalau lagi di Kuala Lumpur atau Bangkok terus ada kejadian serius, nggak perlu keluar kantong dulu sambil nunggu reimbursement berbulan-bulan. Plan-nya cover Asia, kecuali Hong Kong, Jepang, dan Singapura — tapi itu sudah mencakup sebagian besar wilayah yang biasa dikunjungi orang Indonesia.”

The Four Killer Diseases Sub-Section

“The four conditions SHIFA Essential covers are not random — they’re the four leading causes of serious long-term hospitalisation in Indonesia: stroke, cancer, cardiovascular disease (that’s heart attacks and arterial disease), and kidney failure. These four conditions together account for the majority of catastrophic medical bills. If you’re protected against these four, you’re protected against the most likely financial disasters from illness.”

“Empat penyakit yang di-cover SHIFA Essential itu bukan pilihan sembarangan — mereka adalah empat penyebab utama rawat inap jangka panjang yang berat di Indonesia: stroke, kanker, penyakit kardiovaskular (serangan jantung dan penyakit pembuluh darah), dan gagal ginjal. Keempat penyakit ini secara gabungan menyebabkan sebagian besar tagihan medis yang besar dan tidak terduga. Kalau kamu sudah terlindungi dari empat ini, kamu sudah terlindungi dari risiko finansial terbesar akibat penyakit.”

The Close

“SHIFA Essential is not asking you to predict which illness will hit you. It covers the four most likely ones, pays your actual bills, and resets the limit every year. For someone who hasn’t sorted out serious-illness cover yet, and who wants a syariah structure, this is genuinely worth looking at. The entry price for the Indonesia plan starts below Rp 150,000 per month for a 40-year-old — and the protection you’re getting at the Rp 500 million annual limit is real.”

“SHIFA Essential bukan minta kamu tebak penyakit apa yang bakal datang. Dia cover empat yang paling sering terjadi, bayar tagihan yang sebenarnya, dan limitnya reset tiap tahun. Buat yang belum punya perlindungan untuk penyakit berat, dan pengen struktur yang syariah, ini layak untuk dipertimbangkan. Untuk Plan Indonesia, harga mulainya di bawah Rp 150.000 per bulan untuk usia 40 tahun — dan perlindungan Rp 500 juta per tahun itu nyata, bukan sekadar angka di brosur.”

7. Top 5 Customer Objections + Handling

Customer-facing script — use the EN / ID toggle (top-right) to switch language.

Objection 1: “My company already gives me health insurance — I don’t need this.”

EN (Don't say) “Well then you probably don’t need this.”

EN (Do say) “Your employer health plan is great for everyday illness — flu, infections, minor surgeries. But most employer plans have a coverage cap, and when it comes to something like a cancer diagnosis, the bills can run into hundreds of millions over several years. SHIFA Essential is specifically for those four serious conditions — stroke, cancer, heart disease, kidney failure. Here’s the kicker: even if your employer plan already paid the bill, SHIFA Essential pays you an additional 50% of the approved amount on top. So they work together, not against each other.”

ID (Jangan bilang) “Oh kalau gitu mungkin memang nggak perlu.”

ID (Coba bilang) “Kartu kesehatan dari kantor itu bagus untuk sakit-sakit biasa — flu, infeksi, operasi ringan. Tapi kebanyakan kartu kesehatan kantor ada batasnya, dan kalau kena kanker misalnya, tagihannya bisa ratusan juta per tahun selama bertahun-tahun. SHIFA Essential itu khusus untuk empat penyakit berat — stroke, kanker, jantung, gagal ginjal. Bahkan yang menarik: meskipun asuransi kantor kamu sudah bayar tagihannya, SHIFA Essential tetap bisa bayar tambahan 50% dari tagihan yang disetujui. Jadi keduanya jalan bersamaan, bukan saling bertentangan.”

Objection 2: “BPJS Kesehatan is enough — why would I pay extra?”

EN (Don't say) “BPJS is okay but it’s not good enough.”

EN (Do say) “BPJS is a great safety net. But BPJS covers treatment at BPJS-registered rates, which means you may be in a shared ward, waiting for specialist appointments, and navigating referral requirements. For a serious condition like cancer or kidney failure, where ongoing treatment runs for years, many families find the BPJS experience is workable but stressful. SHIFA Essential is a private specialist-grade overlay for just those four conditions. You keep your BPJS — SHIFA works alongside it. The gap SHIFA fills is private rooms, faster access, and out-of-pocket costs that BPJS doesn’t cover.”

ID (Jangan bilang) “BPJS itu kurang memadai.”

ID (Coba bilang) “BPJS itu bagus sebagai jaring pengaman. Tapi BPJS cover perawatan sesuai tarif BPJS — artinya mungkin di bangsal biasa, antri ke dokter spesialis, dan harus lewat proses rujukan. Untuk penyakit berat seperti kanker atau gagal ginjal yang penanganannya bisa bertahun-tahun, banyak keluarga yang merasa proses BPJS-nya bisa dijalani tapi melelahkan. SHIFA Essential itu lapisan tambahan untuk empat penyakit itu — kelas spesialis swasta. BPJS-nya tetap jalan; SHIFA jalan di sampingnya. Yang SHIFA isi adalah: kamar pribadi, akses lebih cepat, dan biaya yang tidak di-cover BPJS.”

Objection 3: “BSI has takaful health products — why not just use those?”

EN (Don't say) “BSI products are not as good.”

EN (Do say) “BSI takaful health products are worth looking at for general hospitalisation. Where SHIFA Essential is different is the CI-specific focus and the annual benefit limit — up to Rp 2 billion per condition per year, with Asian geographic coverage. If your concern is specifically stroke, cancer, heart disease, or kidney failure, and you want genuine large-scale financial protection for those conditions specifically, SHIFA Essential’s annual limit structure is hard to match. That said, BSI products and SHIFA Essential serve different purposes and could coexist — one for general hospitalisation, one for catastrophic CI costs.”

ID (Jangan bilang) “Produk BSI kurang bagus.”

ID (Coba bilang) “Produk takaful kesehatan dari BSI itu menarik untuk rawat inap umum. Bedanya SHIFA Essential itu fokus spesifik ke penyakit kritis, dengan batas manfaat tahunan yang besar — sampai Rp 2 miliar per penyakit per tahun, plus coverage sampai ke Asia. Kalau yang kamu khawatirkan khusus stroke, kanker, jantung, atau gagal ginjal, dan mau proteksi finansial besar untuk penyakit-penyakit itu secara khusus, struktur batas tahunan SHIFA Essential ini susah ditandingi. Tapi sebenarnya produk BSI dan SHIFA Essential bisa jalan berdampingan — satu untuk rawat inap umum, satu untuk biaya penyakit kritis yang besar.”

Objection 4: “Only four diseases seems very limited.”

EN (Don't say) “Well, that’s the product design.”

EN (Do say) “Four conditions sounds narrow until you look at the data. Stroke, cancer, cardiovascular disease, and kidney failure are the four conditions responsible for the largest single medical bills in Indonesia. They’re the ones that bankrupt families. A product that covers all conditions for a little bit is less useful than one that covers the four most financially devastating ones deeply — with up to Rp 2 billion per condition per year. And unlike a general health plan, SHIFA Essential’s annual limit resets every year, so a cancer patient who needs multi-year treatment gets covered year after year.”

ID (Jangan bilang) “Memang begitu desain produknya.”

ID (Coba bilang) “Empat penyakit kedengarannya sedikit, sampai kamu lihat datanya. Stroke, kanker, penyakit jantung, dan gagal ginjal itu empat penyebab tagihan medis terbesar di Indonesia. Mereka yang bikin keluarga bisa jatuh miskin dalam semalam. Produk yang cover semua penyakit sedikit-sedikit itu kurang berguna dibanding yang cover empat penyakit paling merusak secara finansial dengan dalam — sampai Rp 2 miliar per penyakit per tahun. Dan berbeda dari asuransi kesehatan umum, batas tahunan SHIFA Essential itu reset tiap tahun, jadi pasien kanker yang butuh pengobatan bertahun-tahun tetap di-cover dari tahun ke tahun.”

Objection 5: “I want a lump sum, not reimbursement — if I get cancer I want cash to use however I want.”

EN (Don't say) “Reimbursement is actually better.”

EN (Do say) “That’s a completely valid preference, and it should drive which product you choose. If you want cash freedom — money you can use to pay household expenses, take a treatment abroad, or support your family’s income while you’re recovering — then a CI lump-sum product is the right structure for you, and I can show you that. SHIFA Essential is built for a different purpose: covering the actual medical bills for those four conditions so your savings don’t get wiped out by treatment costs. Many people actually want both — a lump-sum for income and flexibility, and a health cover so the bills don’t eat the lump sum. Those two products work together.”

ID (Jangan bilang) “Reimbursement sebenarnya lebih bagus.”

ID (Coba bilang) “Itu preferensi yang sangat valid, dan itu yang harusnya tentukan produk mana yang cocok buat kamu. Kalau kamu mau kebebasan cash — uang yang bisa dipakai untuk biaya rumah tangga, coba pengobatan di luar negeri, atau topang penghasilan keluarga selama kamu recovery — maka produk CI lump-sum itu yang tepat, dan saya bisa tunjukkan itu. SHIFA Essential dibuat untuk tujuan yang beda: cover tagihan medis yang sebenarnya untuk empat penyakit itu supaya tabunganmu nggak habis terkuras biaya perawatan. Banyak orang sebenarnya butuh keduanya — lump-sum untuk fleksibilitas dan pendapatan, plus health cover supaya tagihannya nggak menghabiskan uang lump-sum itu. Kedua produk itu bisa jalan bareng.”

Objection 6: “Is this really syariah, or is it just branded syariah?”

EN (Don't say) “Yes, it’s syariah, trust me.”

EN (Do say) “That’s a fair and important question, and I’d rather give you a direct answer than a sales pitch. SHIFA Essential uses two formal Islamic contracts: Akad Tabarru’ — which is a donation/mutual pooling arrangement where your contribution joins a collective risk fund, and claims are paid from that pool; and Akad Wakalah bil Ujrah — where Sun Life acts as your appointed agent to manage that fund, and charges a disclosed fee for that service. Sun Life Indonesia was actually the first conventional insurer to fully separate its syariah and conventional operations, and its syariah division is OJK-regulated. The structure is not just branding — it is a documented legal structure that excludes riba, gharar, and maysir. You should still read the policy document and satisfy yourself, but the akad structure is genuine.”

ID (Jangan bilang) “Iya, ini syariah, percaya saja.”

ID (Coba bilang) “Pertanyaan yang bagus dan penting — dan saya lebih baik jawab langsung daripada sekedar jual produk. SHIFA Essential pakai dua akad Islam resmi: Akad Tabarru’ — itu semacam hibah gotong royong, kontribusimu masuk ke dana kolektif, dan klaim dibayar dari dana itu; dan Akad Wakalah bil Ujrah — di mana Sun Life jadi wakil yang ditunjuk untuk mengelola dana itu, dan mengambil fee yang sudah diungkapkan secara transparan. Sun Life Indonesia bahkan perusahaan asuransi jiwa pertama di Indonesia yang benar-benar memisahkan operasional konvensional dan syariah-nya, dan divisi syariah-nya diawasi OJK. Strukturnya bukan sekadar label — ini struktur hukum yang terdokumentasi dan menghindari riba, gharar, dan maysir. Silakan baca polis-nya sendiri dan pastikan, tapi akad-nya memang genuine.”

8. Compliance Red Flags and Mis-Selling Warnings

1. Reimbursement vs lump-sum — critical disclosure The single most important disclosure at point of sale. SHIFA Essential pays actual medical bills up to the annual limit. It does NOT pay a lump sum on diagnosis. Any agent who describes this product as “dapat uang tunai kalau kena penyakit kritis” (you receive cash when you’re diagnosed with CI) is mis-selling. The distinction must be explained clearly, and the customer must confirm understanding before application is submitted.

2. 180-day waiting period — non-negotiable Symptoms, investigations, or a diagnosis of any of the four covered conditions that occur within the first 180 days of the policy being in force (or 180 days from the most recent policy reinstatement) result in a total claim denial for that condition. The policy will not cover that condition ever again. Agents must disclose this before sale, not after a claim is denied. If a customer has any current or recent history of the four conditions, the agent must advise underwriting review before taking an application.

3. Annual renewable means contribution is not fixed Contributions are reviewed at each policy anniversary. Sun Life can change the contribution rate with 30 business days’ notice. In an environment of rising medical inflation in Indonesia, historical contribution levels are not a guide to future costs. Agents must not imply or state that the current annual figure will remain constant. The phrase “kontribusi bisa berubah setiap tahun” must be in the agent’s disclosure.

4. Geographic coverage fine print — Asia excludes HK, Japan, Singapore The three excluded markets are Hong Kong, Japan, and Singapore — the three most commonly visited Asian destinations for Indonesian business travellers and frequent flyers. Customers who specifically need coverage in those markets need to be redirected to a different product or supplemented with travel/expat health insurance. Agents must not describe the Asia plans as “coverage across Asia” without specifying the three exclusions.

5. Tabarru’ fund deficit risk The Tabarru’ pool can run a deficit if claims exceed contributions. In a deficit scenario, Sun Life provides a Qardh (interest-free loan) to cover shortfalls. This Qardh must be repaid from future surpluses before surplus sharing resumes. Customers should be aware that the strength of the syariah fund is partly dependent on Sun Life’s financial health and willingness to provide Qardh. This must be disclosed as a risk, not buried.

6. Ujrah 55% must be disclosed The Wakalah fee structure allocates 55% of every contribution to Sun Life as a management fee, with only 45% entering the Tabarru’ risk pool. This is a material fact. Agents must disclose the Ujrah percentage when discussing contribution structure. Failure to disclose is a compliance violation under POJK regulations governing syariah insurance products.

7. One SHIFA Essential policy per insured — limit Each insured person can hold only one SHIFA Essential policy. If a customer already has an existing SHIFA Essential policy (however sold — agency or bancassurance), a second application must be rejected. Agents must verify this at application stage.

8. POJK 36/2025 co-payment (Risiko Sendiri) disclosure Under the regulatory environment in force, customers must be informed of any co-payment or self-retention provisions. The room-upgrade prorata formula in SHIFA Essential (if a customer upgrades their room above plan entitlement, all benefits are proportionally reduced) functions as a de facto co-payment. Agents must explain this clearly: taking a room above the plan’s maximum daily room rate will trigger proportional reductions across all benefits, not just the room benefit.


9. Quick-Reference Spec Card


BASIC

Product name

Salam Healthier Future

Assurance (SHIFA) Essential

Insurer

PT Sun Life Financial

Indonesia (Syariah Division)

Jenis produk

Asuransi kesehatan /

CI-triggered health

reimbursement

OJK approved

Yes; regulatory ref in

RIPLAY CIMB_v.1/SLFI/2026

Channel

Agency (agency-specific

version noted as v0.8 in

master-log; CIMB Niaga

Syariah bancassurance

version also exists)

TERMS

Policyholder

Age 18–80 years

Insured

Age 20–60 years

Coverage term

1 year, renewable to

insured age 100

Payment term

Max to insured age 99

Frequency

Annual

Min contrib.

Rp 1,478,000/year

Contrib. note

NOT guaranteed; can

change at each renewal

with 30 business days

notice

Sample case

Male, 40, Plan Indo 1

= Rp 2,024,000/year

1 policy per

1 insured (cannot hold

2 SHIFA Essential policies)

4 COVERED CONDITIONS

1. Stroke

2. Cancer (Kanker)

3. Cardiovascular disease

(Penyakit Jantung dan

Pembuluh Darah Jantung)

4. Kidney failure (Gagal Ginjal)

Coverage is triggered by formal

medical diagnosis of one of these

4 conditions. Policy does NOT

cover any other condition.

PLAN COMPARISON

Plan Annual Geography Room/night

Limit (max)

----------- ------- ------------ ----------

Indo 1 Rp 500M Indonesia Rp 1.0M

(twin)

Indo 2 Rp 1.0B Indonesia Rp 1.0M

(twin)

Asia 1 Rp 1.0B Asia* Rp 1.5M

(single)

Asia 2 Rp 2.0B Asia* Rp 1.5M

(single)

* Excludes Hong Kong, Japan, Singapore

Death benefit per plan

Indo 1 / Indo 2:Rp 200,000,000

Asia 1:Rp 300,000,000

Asia 2:Rp 400,000,000

Celebration Benefit per plan

Indo 1 / Indo 2:Rp 25,000,000

Asia 1:Rp 30,000,000

Asia 2:Rp 35,000,000

KEY BENEFIT DETAILS

Max hosp days

150 days/year

ICU

Actual cost

Doctor visits

Actual cost;

max 2/day during hosp

Surgery

Actual cost

Dialysis

Max Rp 200M/year

Kidney transplant

Max Rp 750M each;

max 2 per policy life;

outside annual limit

Palliative (K)

Actual cost; inpt+outp

Cancer monitoring

5 yrs post-treatment

CI Allowance

50% of approved bill

minus other insurer

payout (if any);

reduces annual limit

Recovery benefits (per condition)

Nutritionist:Rp 300K–650K/visit; max 60 visits

Psychologist:Rp 400K–800K/visit; max 30 visits

Physio/OT/ST:Rp 300K–650K/visit; max 90 visits

Home care:Rp 500K–800K/day; max 60 days

Medical aids:Rp 25M–45M per cond.

Wig (cancer):Rp 4M–5M once

Stroke equip:Rp 30M–50M once

WAITING PERIODS

CI coverage

180 days from policy

start OR from last

reinstatement date

(whichever is later)

During waiting

Accidental causes may

period

be exempt (subject to

policy terms)

Post-waiting

No condition-specific

waiting periods noted

beyond the initial 180

Note

If diagnosed during waiting

period, that specific condition is

permanently excluded going forward.

EXCLUSIONS (NOTABLE)

- Pre-existing conditions (unless

waived in writing by Sun Life)

- Diagnosis or symptoms during

180-day waiting period

- Drug/alcohol use or abuse

- Cosmetic/elective surgery

- Medical check-ups, screening,

prevention (no active diagnosis)

- HIV/AIDS

- Experimental treatments not

approved by Indonesian authorities

- Mental/psychiatric conditions

(depression, dementia, Alzheimer's)

- Pregnancy, childbirth, and related

- War, terrorism, nuclear/bio/chem

- Professional sports, motor racing,

hazardous activities (skydiving,

hang gliding, etc.)

- Epidemic or pandemic conditions

declared by WHO or local authority

- Intentional self-harm

SHARIA STRUCTURE

Akad 1

Tabarru' (mutual risk-

sharing donation pool)

Akad 2

Wakalah bil Ujrah

(agency management fee)

Tabarru' split

45% of contribution

Ujrah split

55% of contribution

Policy print

Rp 150,000 if hardcopy

Surplus share

Policyholder 50% /

Sun Life 40% /

Tabarru' 10%

Surplus conds

Policy ≥12 months old;

zero claims in period;

all contributions paid;

policy active at payment

Surplus min

< Rp 50,000 donated

to social institution

Qardh

Sun Life provides

interest-free loan if

Tabarru' fund in deficit;

repaid from future surplus

Regulator

OJK (Otoritas Jasa

Keuangan)

RBC Syariah

220% (as at 30 Sep 2025)

vs 120% minimum

Sun Life

16 KPM Syariah offices

Syariah dist. across Indonesia

10. Action Items for Legacy Income (Next 30 Days)

1. Run a SHIFA Essential vs Allianz comparison training session (Week 1–2) Develop a 45-minute agent training focused on the structural distinction: SHIFA Essential (reimbursement) vs AlliSya CI Hasanah (lump-sum). Agents need to be able to explain clearly why a customer might want one or the other — or both — without defaulting to “Allianz is better.” The comparison must be honest and customer-need-driven. Use the Decision Framework in Section 4 as the training backbone. Target: all agency agents handling syariah products.

2. Identify prospects who could use SHIFA Essential as a top-up referral opportunity (Week 1–3) Review the existing Legacy Income customer book for policyholders who have AlliSya or conventional health/CI products but have expressed interest in syariah-only coverage or have open needs around serious-illness cost coverage. SHIFA Essential is a Sun Life product and cannot be sold by Legacy Income agents, but understanding the competitive landscape helps agents defend against Sun Life Syariah outreach to the same customer base.

3. Build a Muslim-market positioning strategy addressing SHIFA Essential’s market presence (Week 2–3) Sun Life Syariah has 16 KPM Syariah offices nationwide and distributes through CIMB Niaga Syariah bancassurance. The SHIFA brand is already reaching Legacy Income’s target Muslim-market segment through multiple channels. Develop a positioning brief for Legacy Income agents that articulates why AlliSya products (or AlliSya + conventional Allianz combination) serve Muslim customers’ needs, specifically addressing the reimbursement-vs-lump-sum distinction and Allianz’s broader CI condition coverage.

4. Prepare the geographic coverage pitch response for mobile professionals (Week 2) The Asia 1 and Asia 2 plans in SHIFA Essential are a genuine competitive feature — coverage across Asia (ex HK/JP/SG) that most Allianz syariah products do not match directly. Legacy Income agents who serve professionals who travel regionally (Jakarta–Kuala Lumpur, Jakarta–Bangkok corridors) need a prepared response: either articulate which Allianz products offer equivalent or broader geographic coverage, or acknowledge the gap and propose a combination structure. Do not let this go unanswered in the field.

5. Flag the RIPLAY version uncertainty and request the agency-specific document (Week 1) The RIPLAY analysed (CIMB_v.1) is the CIMB Niaga Syariah bancassurance version. The master-log filename suggests an agency-specific version (v0.8-agency) exists. Before this brief is deployed in agent training, obtain the agency-version RIPLAY and verify whether benefit tables, contribution levels, or terms differ from the bancassurance version. Any differences — particularly in contribution pricing or benefit limits — must be updated in this brief before it is used for competitive comparison purposes.


This brief is generated by AI and may contain mistakes. Please exercise discretion. It is intended as an internal user training and positioning resource, not as a customer-facing sales document. All statements about the product are reconstructed from the official RIPLAY and brochure as downloaded 2026-05-03; the policy itself is the binding document. Compliance disclosures, competitor comparisons, and customer-fit guidance reflect analyst judgment and should be reviewed by user before being deployed in agent training materials.

Switch to Expert (top-right) for the full 10-section brief, benchmarks, compliance flags, and source documents.